Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Sep;77(9):5216–5220. doi: 10.1073/pnas.77.9.5216

Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity.

A M Benson, M J Hunkeler, P Talalay
PMCID: PMC350028  PMID: 6933553

Abstract

2(3)-tert-Butyl-4-hydroxyanisole (BHA) is one of several widely used antioxidant food additives that protect against chemical carcinogenesis and toxicity. The present report concerns the enhancement of dicoumarol-inhibited NAD(P)H:quinone reductase [NAD(P)H dehydrogenase (quinone); NAD(P)H:(quinone acceptor) oxidoreductase, EC 1.6.99.2] activity in mouse tissues in response to dietary administration of BHA. Cytosolic quinone reductase specific activity was increased significantly in 10 of 15 tissues examined from BHA-fed mice. The greatest proportionate increase, to 10 times control levels, was observed in liver. BHA also increased the quinone reductase activities of kidney, lung, and the mucosa of the upper small intestine severalfold. The increases of quinone reductase activities in liver and digestive tissues in response to BHA were comparable to the increases previously observed in glutathione S-transferase (EC 2.5.1.18) and epoxide hydratase (EC 3.3.2.3) activities. Quinones are among the toxic products of oxidative metabolism of aromatic hydrocarbons. NAD(P)H:quinone reductase exhibits broad specificity for structurally diverse hydrophobic quinones and may facilitate the microsomal metabolism of quinones to readily excreted conjugates. The protective effects of BHA appear to be due, at least in part, to the ability of this antioxidant to increase the activities in rodent tissues of several enzymes involved in the nonoxidative metabolism of a wide variety of xenobiotics.

Full text

PDF
5216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachur N. R., Gordon S. L., Gee M. V., Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci U S A. 1979 Feb;76(2):954–957. doi: 10.1073/pnas.76.2.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Batzinger R. P., Ou S. Y., Bueding E. Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents. Cancer Res. 1978 Dec;38(12):4478–4485. [PubMed] [Google Scholar]
  3. Beatty P., Neal R. A. Induction of DT-diaphorase by 2,3,7,8-tetrachlorodibenzo-p-dioxin (ICDD). Biochem Biophys Res Commun. 1976 Jan 12;68(1):197–204. doi: 10.1016/0006-291x(76)90029-2. [DOI] [PubMed] [Google Scholar]
  4. Benson A. M., Batzinger R. P., Ou S. Y., Bueding E., Cha Y. N., Talalay P. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res. 1978 Dec;38(12):4486–4495. [PubMed] [Google Scholar]
  5. Benson A. M., Cha Y. N., Bueding E., Heine H. S., Talalay P. Elevation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res. 1979 Aug;39(8):2971–2977. [PubMed] [Google Scholar]
  6. Bueding E., Batzinger R. P., Cha Y. N., Talalay P., Molineaux C. J. Protection from mutagenic effects of antischistosomal and other drugs. Pharmacol Rev. 1978 Dec;30(4):547–554. [PubMed] [Google Scholar]
  7. Calle L. M., Sullivan P. D., Nettleman M. D., Ocasio I. J., Blazyk J., Jollick J. Antioxidants and the mutagenicity of benzo(a) pyrene and some derivatives. Biochem Biophys Res Commun. 1978 Nov 14;85(1):351–356. doi: 10.1016/s0006-291x(78)80049-7. [DOI] [PubMed] [Google Scholar]
  8. Capdevila J., Estabrook R. W., Prough R. A. The existence of a benzo(a)pyrene-3,6-quinone reductase in rat liver microsomal fractions. Biochem Biophys Res Commun. 1978 Aug 29;83(4):1291–1298. doi: 10.1016/0006-291x(78)91361-x. [DOI] [PubMed] [Google Scholar]
  9. Cha Y. N., Bueding E. Effects of 2(3)-tert-butyl-4-hydroxyanisole administration on the activities of several hepatic microsomal and cytoplasmic enzymes in mice. Biochem Pharmacol. 1979 Jun 15;28(12):1917–1921. doi: 10.1016/0006-2952(79)90645-2. [DOI] [PubMed] [Google Scholar]
  10. Cha Y. N., Martz F., Bueding E. Enhancement of liver microsome epoxide hydratase activity in rodents by treatment with 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res. 1978 Dec;38(12):4496–4498. [PubMed] [Google Scholar]
  11. Cumming R. B., Walton M. F. Modification of the acute toxicity of mutagenic and carcinogenic chemicals in the mouse by prefeeding with antioxidants. Food Cosmet Toxicol. 1973 Aug;11(4):547–553. doi: 10.1016/s0015-6264(73)80325-6. [DOI] [PubMed] [Google Scholar]
  12. DAO T. L., TANAKA Y. INHIBITORY EFFECT OF POLYNUCLEAR HYDROCARBONS AND AMPHENONE ANALOGS ON INDUCTION OF ACUTE ADRENAL NECROSIS BY 7,12-DIMETHYLBENZ(ALPHA)ANTHRACENE. Cancer Res. 1963 Sep;23:1148–1152. [PubMed] [Google Scholar]
  13. DiGiovanni J., Berry D. L., Juchau M. R., Slaga T. J. 2,3,7,8-Tetrachlorodibenzo-P-dioxin: potent anticarcinogenic activity in CD-1 mice. Biochem Biophys Res Commun. 1979 Feb 14;86(3):577–584. doi: 10.1016/0006-291x(79)91752-2. [DOI] [PubMed] [Google Scholar]
  14. ERNSTER L., DANIELSON L., LJUNGGREN M. DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties. Biochim Biophys Acta. 1962 Apr 9;58:171–188. doi: 10.1016/0006-3002(62)90997-6. [DOI] [PubMed] [Google Scholar]
  15. Gilbert D., Martin A. D., Gangolli S. D., Abraham R., Goldberg L. The effect of substituted phenols on liver weights and liver enzymes in the rat: structure-activity relationships. Food Cosmet Toxicol. 1969 Nov;7(6):603–619. doi: 10.1016/s0015-6264(69)80463-3. [DOI] [PubMed] [Google Scholar]
  16. HUGGINS C., FUKUNISHI R. INDUCED PROTECTION OF ADRENAL CORTEX AGAINST 7,12-DIMETHYLBENZ(ALPHA)ANTHRACENE. INFLUENCE OF ETHIONINE. INDUCTION OF MENADIONE REDUCTASE. INCORPORATION OF THYMIDINE-H3. J Exp Med. 1964 Jan 1;119:923–942. doi: 10.1084/jem.119.6.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HUGGINS C., MORII S. Selective adrenal necrosis and apoplexy induced by 7, 12-dimethylbenz(a)anthracene. J Exp Med. 1961 Nov 1;114:741–760. doi: 10.1084/jem.114.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. HUGGINS C., PATAKI J. AROMATIC AZO DERIVATIVES PREVENTING MAMMARY CANCER AND ADRENAL INJURY FROM 7,12-DIMETHYLBENZ(A)ANTHRACENE. Proc Natl Acad Sci U S A. 1965 Apr;53:791–796. doi: 10.1073/pnas.53.4.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Haugen D. A., Coon M. J. Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with beta-naphthoflavone or phenobarbital. J Biol Chem. 1976 Mar 25;251(6):1817–1827. [PubMed] [Google Scholar]
  20. Hollander P. M., Ernster L. Studies on the reaction mechanism of DT diaphorase. Action of dead-end inhibitors and effects of phospholipids. Arch Biochem Biophys. 1975 Aug;169(2):560–567. doi: 10.1016/0003-9861(75)90200-3. [DOI] [PubMed] [Google Scholar]
  21. Hommes F. A., Everts R. S., Havinga H. The development of DT-diaphorase in rat liver and its induction by benzo(a)pyrene. Biol Neonate. 1978;34(5-6):248–252. doi: 10.1159/000241136. [DOI] [PubMed] [Google Scholar]
  22. Horning E. C., Thenot J. P., Helton E. D. Toxic agents resulting from the oxidative metabolism of steroid hormones and drugs. J Toxicol Environ Health. 1978 Mar-May;4(2-3):341–361. doi: 10.1080/15287397809529665. [DOI] [PubMed] [Google Scholar]
  23. Hosoda S., Nakamura W., Hayashi K. Properties and reaction mechanism of DT diaphorase from rat liver. J Biol Chem. 1974 Oct 25;249(20):6416–6423. [PubMed] [Google Scholar]
  24. Huang M. T., Miwa G. T., Cronheim N., Lu A. Y. Rat liver cytosolic azoreductase. Electron transport properties and the mechanism of dicumarol inhibition of the purified enzyme. J Biol Chem. 1979 Nov 25;254(22):11223–11227. [PubMed] [Google Scholar]
  25. Huang M. T., Miwa G. T., Lu A. Y. Induction of rat liver cytosol methyl red azo-reductase by 3-methylcholanthrene assayed by a sensitive fluorometric method. Biochem Biophys Res Commun. 1978 Aug 29;83(4):1253–1259. doi: 10.1016/0006-291x(78)91356-6. [DOI] [PubMed] [Google Scholar]
  26. Huang M. T., Miwa G. T., Lu A. Y. Rat liver cytosolic azoreductase. Purification and characterization. J Biol Chem. 1979 May 25;254(10):3930–3934. [PubMed] [Google Scholar]
  27. Huggins C. B., Ueda N., Russo A. Azo dyes prevent hydrocarbon-induced leukemia in the rat. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4524–4527. doi: 10.1073/pnas.75.9.4524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kahl R., Wulff U. Induction of rat hepatic epoxide hydratase by dietary antioxidants. Toxicol Appl Pharmacol. 1979 Feb;47(2):217–227. doi: 10.1016/0041-008x(79)90315-6. [DOI] [PubMed] [Google Scholar]
  29. Kumaki K., Jensen N. M., Shire J. G., Nebert D. W. Genetic differences in induction of cytosol reduced-NAD(P):menadione oxidoreductase and microsomal aryl hydrocarbon hydroxylase in the mouse. J Biol Chem. 1977 Jan 10;252(1):157–165. [PubMed] [Google Scholar]
  30. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  31. Lam L. K., Wattenberg L. W. Effects of butylated hydroxyanisole on the metabolism of benzo[a]pyrene by mouse liver microsomes. J Natl Cancer Inst. 1977 Feb;58(2):413–417. doi: 10.1093/jnci/58.2.413. [DOI] [PubMed] [Google Scholar]
  32. Levin W., Lu A. Y., Thomas P. E., Ryan D., Kizer D. E., Griffin M. J. Identification of epoxide hydrase as the preneoplastic antigen in rat liver hyperplastic nodules. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3240–3243. doi: 10.1073/pnas.75.7.3240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lind C., Ernster L. A possible relationship between DT diaphorase and the aryl hydrocarbon hydroxylase system. Biochem Biophys Res Commun. 1974 Jan 23;56(2):392–400. doi: 10.1016/0006-291x(74)90855-9. [DOI] [PubMed] [Google Scholar]
  34. Lind C., Vadi H., Ernster L. Metabolism of benzo(a)pyrene-3,6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. A possible role of DT-diaphorase in the formation of glucuronyl conjugates. Arch Biochem Biophys. 1978 Sep;190(1):97–108. doi: 10.1016/0003-9861(78)90256-4. [DOI] [PubMed] [Google Scholar]
  35. Lorentzen R. J., Lesko S. A., McDonald K., Ts'o P. O. Toxicity of metabolic benzo(a)pyrenediones to cultured cells and the dependence upon molecular oxygen. Cancer Res. 1979 Aug;39(8):3194–3198. [PubMed] [Google Scholar]
  36. MAERKI F., MARTIUS C. [Vitamin K reductase, preparation and properties]. Biochem Z. 1960;333:111–135. [PubMed] [Google Scholar]
  37. McKee R. H., Tometsko A. M. Inhibition of promutagen activation by the antioxidants butylated hydroxyanisole and butylated hydroxytoluene. J Natl Cancer Inst. 1979 Aug;63(2):473–477. [PubMed] [Google Scholar]
  38. Pelkonen O., Boobis A. R., Yagi H., Jerina D. M., Nebert D. W. Tentative identification of benzo[a]pyrene metabolite-nucleoside complexes produced in vitro by mouse liver microsomes. Mol Pharmacol. 1978 Mar;14(2):306–322. [PubMed] [Google Scholar]
  39. Rahimtula A. D., Zachariah P. K., O'Brien P. J. The effects of antioxidants on the metabolism and mutagenicity of benzo[a]pyrene in vitro. Biochem J. 1977 May 15;164(2):473–475. doi: 10.1042/bj1640473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rase B., Bartfai T., Ernster L. Purification of DT-diaphorase by affinity chromatography. Occurrence of two subunits and nonlinear Dixon and Scatchard plots of the inhibition by anticoagulants. Arch Biochem Biophys. 1976 Feb;172(2):380–386. doi: 10.1016/0003-9861(76)90089-8. [DOI] [PubMed] [Google Scholar]
  41. Schor N. A., Boh E., Burke V. T. Carcinogens and dicumarol: opposite effects on rat liver NAD(P)H dehydrogenation. Enzyme. 1978;23(4):217–224. doi: 10.1159/000458583. [DOI] [PubMed] [Google Scholar]
  42. Schor N. A., Morris H. P. The activity of the D-T diaphorase in experimental hepatomas. Cancer Biochem Biophys. 1977;2(1):5–9. [PubMed] [Google Scholar]
  43. Schor N. A. The use of the D-T diaphorase for the detection of foci of early neoplastic transformation in rat liver. Cancer Lett. 1978 Sep;5(3):167–171. doi: 10.1016/s0304-3835(78)80034-2. [DOI] [PubMed] [Google Scholar]
  44. Speier J. L., Lam L. K., Wattenberg L. W. Effects of administration to mice of butylated hydroxyanisole by oral intubation on benzo[a]pyrene-induced pulmonary adenoma formation and metabolism of benzo[a]pyrene. J Natl Cancer Inst. 1978 Mar;60(3):605–609. doi: 10.1093/jnci/60.3.605. [DOI] [PubMed] [Google Scholar]
  45. Speier J. L., Wattenberg L. W. Alterations in microsomal metabolism of benzo[a]pyrene in mice fed butylated hydroxyanisole. J Natl Cancer Inst. 1975 Aug;55(2):469–472. [PubMed] [Google Scholar]
  46. Stenflo J., Suttie J. W. Vitamin K-dependent formation of gamma-carboxyglutamic acid. Annu Rev Biochem. 1977;46:157–172. doi: 10.1146/annurev.bi.46.070177.001105. [DOI] [PubMed] [Google Scholar]
  47. Suzuki H., Nakao T., Hiraga K. Vitamin K deficiency in male rats fed diets containing butylated hydroxytoluene (BHT). Toxicol Appl Pharmacol. 1979 Sep 15;50(2):261–266. doi: 10.1016/0041-008x(79)90151-0. [DOI] [PubMed] [Google Scholar]
  48. Takahashi O., Hiraga K. The relationship between hemorrhage induced by butylated hydroxytoluene and its antioxidant properties or structural characteristics. Toxicol Appl Pharmacol. 1978 Dec;46(3):811–814. doi: 10.1016/0041-008x(78)90326-5. [DOI] [PubMed] [Google Scholar]
  49. Talalay P., Batzinger R. P., Benson A. M., Bueding E., Cha Y. N. Biochemical studies on the mechanisms by which dietary antioxidants suppress mutagenic activity. Adv Enzyme Regul. 1978;17:23–36. doi: 10.1016/0065-2571(79)90006-2. [DOI] [PubMed] [Google Scholar]
  50. WILLIAMS-ASHMAN H. G., HUGGINS C. Oxydation of reduced pyridine nucleotides in mammary gland and adipose tissue following treatment with polynuclear hydrocarbons. Med Exp Int J Exp Med. 1961;4:223–226. doi: 10.1159/000135017. [DOI] [PubMed] [Google Scholar]
  51. WOSILAIT W. D. The reduction of vitamin K1 by an enzyme from dog liver. J Biol Chem. 1960 Apr;235:1196–1201. [PubMed] [Google Scholar]
  52. Wallin R., Gebhardt O., Prydz H. NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction. Biochem J. 1978 Jan 1;169(1):95–101. doi: 10.1042/bj1690095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wattenberg L. W. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J Natl Cancer Inst. 1972 May;48(5):1425–1430. [PubMed] [Google Scholar]
  54. Wattenberg L. W. Inhibitors of chemical carcinogenesis. Adv Cancer Res. 1978;26:197–226. doi: 10.1016/s0065-230x(08)60088-3. [DOI] [PubMed] [Google Scholar]
  55. Wislocki P. G., Wood A. W., Chang R. L., Levin W., Yagi H., Hernandez O., Dansette P. M., Herina D. M., Conney A. H. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. Cancer Res. 1976 Sep;36(9 PT1):3350–3357. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES